These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1498098)

  • 1. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of tyrosinase-negative oculocutaneous albinism. A single base mutation in the tyrosinase gene causing arginine to glutamine substitution at position 59.
    Takeda A; Tomita Y; Matsunaga J; Tagami H; Shibahara S
    J Biol Chem; 1990 Oct; 265(29):17792-7. PubMed ID: 2120217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R278TER and P431L mutations of the tyrosinase gene exist in Japanese patients with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Shimizu H; Tomita Y
    J Dermatol Sci; 1996 Nov; 13(2):134-9. PubMed ID: 8953413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the tyrosinase gene in oculocutaneous albinism.
    Shibahara S
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper.
    Matsunaga J; Dakeishi-Hara M; Miyamura Y; Nakamura E; Tanita M; Satomura K; Tomita Y
    Dermatology; 1998; 196(2):189-93. PubMed ID: 9568405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
    Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
    Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
    Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual.
    Oetting WS; Fryer JP; King RA
    Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA; Mentink MM; Oetting WS
    Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
    King RA; Oetting WS
    Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene.
    Tomita Y; Takeda A; Matsunaga J; Okinaga S; Shibahara S; Tagami H
    Pigment Cell Res; 1992; Suppl 2():96-100. PubMed ID: 1409445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB; Tripathi RK; King RA; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electron microscopic DOPA reaction test for oculocutaneous albinism.
    Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H
    Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
    Oetting WS
    Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
    Giebel LB; Musarella MA; Spritz RA
    J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants.
    Halaban R; Cheng E; Hebert DN
    J Invest Dermatol; 2002 Aug; 119(2):481-8. PubMed ID: 12190874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1).
    Oetting WS; King RA
    Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.